MENU

MAZE Maze Therapeutics Inc Forecast, Technical & Fundamental Analysis

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity... Show more

MAZE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
MAZE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MAZE is expected to report earnings to fall 25.00% to -56 cents per share on November 05

Maze Therapeutics Inc MAZE Stock Earnings Reports
Q3'26
Est.
$-0.57
Q2'26
Missed
by $0.19
Q1'26
Beat
by $0.13
Q4'25
Missed
by $0.02
Q3'25
Missed
by $0.04
The last earnings report on August 11 showed earnings per share of -75 cents, missing the estimate of -56 cents. With 994.24K shares outstanding, the current market capitalization sits at 1.58B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
171 Oyster Point boulevard
Phone
+1 650 850-5070
Employees
141
Web
https://www.mazetx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIISX15.820.07
+0.44%
Nuveen Quant Intl Small Cap Eq R6
ABALX40.450.04
+0.10%
American Funds American Balanced A
ACLAX16.37N/A
N/A
American Century Mid Cap Value A
AAIEX20.06-0.03
-0.15%
American Beacon International Eq R5
IVITX21.30-0.09
-0.42%
VY® Invesco Growth and Income S2

MAZE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MAZE has been loosely correlated with AVXL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MAZE jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAZE
1D Price
Change %
MAZE100%
+26.75%
AVXL - MAZE
46%
Loosely correlated
+2.92%
VKTX - MAZE
40%
Loosely correlated
+35.67%
IMNM - MAZE
38%
Loosely correlated
+2.71%
ADMA - MAZE
35%
Loosely correlated
+3.21%
FDMT - MAZE
31%
Poorly correlated
+4.20%
More
Maze Therapeutics (MAZE) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com